Insider · CIK 0001329646
George Bickerstaff
director
Files at CDNA (CareDx, Inc.). First filing Mar 12, 2025, latest Mar 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $367k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CDNA: CareDx, Inc.
CDNAOct 9, 2026 · close 63.67
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CDNA CareDx, Inc. | MOption exercise Common Stock | +29,136 | $7.96 | $232k | 144,266 | Sep 12, 2025 |
| Sep 11, 2025 | CDNA CareDx, Inc. | MOption exercise Stock Option (right to buy)derivative | -29,136 | $0.00 | $0 | 0 | Sep 12, 2025 |
| Jun 13, 2025 | CDNA CareDx, Inc. | AGrant or award Common Stock | +12,103 | $0.00 | $0 | 115,130 | Jun 17, 2025 |
| Mar 10, 2025 | CDNA CareDx, Inc. | SOpen-market sale Common Stock | -20,000 | $18.36 | $367k | 103,027 | Mar 12, 2025 |
| Nov 1, 2024 | CDNA CareDx, Inc. | MOption exercise Common Stock | +5,255 | $5.85 | $31k | 120,801 | Nov 5, 2024 |
| Nov 1, 2024 | CDNA CareDx, Inc. | MOption exercise Common Stock | +2,226 | $5.49 | $12k | 123,027 | Nov 5, 2024 |
| Nov 1, 2024 | CDNA CareDx, Inc. | MOption exercise Stock Option (right to buy)derivative | -5,255 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Nov 1, 2024 | CDNA CareDx, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,226 | $0.00 | $0 | 0 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.